Similar articles

• Living-unrelated renal transplantation.

  Simforoosh N, Bassiri A, Amiransari B, Gol S. Simforoosh N, et al. Transplant Proc. 1992 Dec;24(6):2421-2. Transplant Proc. 1992. PMID: 1465814 No abstract available.
• DR6 compatibility and kidney graft survival.

  Correia AM, de Costa AG, Reis P, Rego F, Sampaio MJ, Caetano JM, Pena JR. Correia AM, et al. Transplant Proc. 1992 Dec;24(6):2472. Transplant Proc. 1992. PMID: 1465836 No abstract available.
• Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation.

  Arbelaez M, Mejia G, Henao JE, Garcia A, Arango JL, Velasquez A, Restrepo J, Garcia LF. Arbelaez M, et al. Transplant Proc. 1992 Dec;24(6):3096-7. Transplant Proc. 1992. PMID: 1466072 No abstract available.
• [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].

  Cherqui D, Duvoux C, Charlotte F, Humeres R, Lauzet JY, Métreau JM, Salvat A, Rotman N, Julien M, Fagniez PL, et al. Cherqui D, et al. Gastroenterol Clin Biol. 1994;18(2):115-22. Gastroenterol Clin Biol. 1994. PMID: 8013792 Review. French.
• Malignant tumours after renal transplantation.

  Fahlenkamp D, Reinke P, Kirchner S, Schnorr D, Lindeke A, Loening SA. Fahlenkamp D, et al. Scand J Urol Nephrol. 1996 Oct;30(5):357-62. doi: 10.3109/00365599609181310. Scand J Urol Nephrol. 1996. PMID: 8936623 Review.